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Abstract
Somatic variants can be used as lineage markers for the phylogenetic reconstruction of cancer evolution. Since
somatic phylogenetics is complicated by sample heterogeneity, novel specialized tree-building methods are required
for cancer phylogeny reconstruction. We present LICHeE (Lineage Inference for Cancer Heterogeneity and
Evolution), a novel method that automates the phylogenetic inference of cancer progression from multiple somatic
samples. LICHeE uses variant allele frequencies of SSNVs obtained by deep sequencing to reconstruct multi-sample
cell lineage trees and infer the subclonal composition of the samples. LICHeE is open-sourced and available at
http://viq854.github.io/lichee.
Background
Cancer is driven by the accumulation of somatic muta-
tions that confer fitness advantages to the tumor cells.
Numerous studies have shown tumors to be highly het-
erogeneous, consisting of mixtures of cell subpopula-
tions with distinct sets of somatic variants (for exam-
ple see review papers [1, 2]). With the advent of next-
generation sequencing technologies, many large-scale
efforts are underway to catalog the somatic mutational
events driving the progression of cancer [3, 4] and in-
fer the phylogenetic relationships of tumor subclones.
Characterizing the heterogeneity and inferring tumor
phylogenies are key steps for developing targeted can-
cer therapies [5] and understanding the biology and
progression of cancer.
In order to reconstruct tumor phylogenies, studies
have utilized variant allele frequency (VAF) data of
somatic single nucleotide variants (SSNVs) obtained
by whole-genome [6, 7], exome [8], and targeted deep
sequencing [6, 9]. Clustering of SSNVs based on VAF
similarity [10–12] and detection of copy number aber-
rations, while accounting for variable sample purity
[8, 13, 14], have been used to differentiate and order
groups of mutational events. While many evolution-
ary studies of cancer have focused on single-sample
intra-tumor heterogeneity [15], several studies have
also compared multiple tumor samples extracted from
a single patient either at different points in time dur-
ing cancer progression [16–18] or from different re-
gions of the same tumor or its metastases [7,19–23]. In
multi-sample approaches, the patterns of SSNV shar-
ing (i.e., distinguishing somatic mutations that are om-
nipresent, partially shared, or private among the sam-
ples) can serve as phylogenetic markers from which
lineage trees are reconstructed [24]. On the basis of
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the lineage trees, the evolutionary timing of each mu-
tational event can then be inferred with high confi-
dence [7, 17,19,25].
Most existing multi-sample studies with a relatively
small number of SSNVs infer the tumor phylogenies
manually by analyzing SSNV VAFs and presence pat-
terns across samples [7, 22, 26]. Several other stud-
ies used implementations of traditional phylogeny re-
construction methods, such as neighbor joining with
Pearson correlation distances [27], or maximum parsi-
mony [21] on patterns of somatic mutational sharing
across samples. However, in order to scale to datasets
comprised of large numbers of samples per patient and
extract fine-grained SSNV timing information, as well
as handle sample heterogeneity, which traditional tree-
building techniques are not designed to do, specialized
computational approaches need to be developed for tu-
mor cell lineage reconstruction. Two recent computa-
tional methods, SubcloneSeeker [28] and PhyloSub [29],
have been developed to address this need. The method
SubcloneSeeker requires as input clusters of variant cell
prevalence (CP) estimates that need to be obtained by
processing the data using other existing tools. Given
the CP clusters, the method generates all possible sub-
clone structures in each sample separately. The per-
sample solutions are then trimmed by checking their
compatibilities during the merge step. However, the
merge step is designed to check compatibilities of two
tumor samples only (e.g. relapse/primary tumor sam-
ple pairs that are common in clinical studies) and it
cannot merge the subclone structures of more than
two samples. Currently it only reports which sample
trees are compatible across the given pair of samples.
The method PhyloSub performs reasonably on sam-
ples with very few mutations that form simple (chain)
topologies; however, it produces unsatisfactory results
on larger multi-sample datasets, such as [21] (see Ap-
pendix A for details).
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In this work we introduce LICHeE (Lineage Inference
for Cancer Heterogeneity and Evolution), a novel
computational method for the reconstruction of multi-
sample tumor phylogenies and tumor subclone de-
composition from targeted deep sequencing SSNV
datasets. Given SSNV VAFs from multiple samples,
LICHeE finds the set of lineage trees that are con-
sistent with the SSNV presence patterns and VAFs
within each sample and are valid under the cell divi-
sion process. Given each such tree, LICHeE provides
estimates of the subclonal mixtures of the samples
by inferring sample heterogeneity simultaneously with
phylogenetic cell lineage tree reconstruction. LICHeE
is able to search for lineage trees very efficiently by in-
corporating the SSNVs into an evolutionary constraint
network that embeds all such trees and applying VAF
constraints to reduce the search space. LICHeE runs
in only a few seconds given hundreds of input SSNVs
and does not require data preprocessing.
We demonstrate that LICHeE is highly effective in
reconstructing the lineage trees and sample hetero-
geneity by evaluating it on simulated trees of heteroge-
neous cancer cell lineage evolution, as well as on three
recently published ultra-deep sequencing multi-sample
datasets of clear cell renal cell carcinoma (ccRCC) by
Gerlinger et. al [21], high-grade serous ovarian cancer
(HGSC) by Bashashati et. al [27], and breast cancer
xenoengraftment in immunodeficient mice by Eirew et.
al [30], for which single-cell validation results are also
available. LICHeE found unique trees for each ccRCC
patient and for all except one patient (for which multi-
ple valid trees were found) of the HGSC study. For the
ccRCC dataset, LICHeE trees were nearly identical to
the published trees, which are the result of a multi-
step thorough analysis of the data, involving SSNV
calling, clustering, and tree-building using maximum
parsimony. For the HGSC dataset, LICHeE improved
on the results reported by the study, producing trees
with better support from the data. LICHeE also re-
vealed additional heterogeneity in the samples of both
studies. In particular, LICHeE identified subclones in
one more sample of the ccRCC study (in addition to
the reported six samples) and three samples of the
HGSC study, all supported by the data. Finally, the
trees reconstructed by LICHeE on the xenoengraft-
ment dataset can be highly-validated by the single-
cell analysis presented in the paper. LICHeE is open-
source and freely distributed at [31], and includes an
intuitive graphical user interface (GUI) that may aid
users to perform quality control on the output trees as
well as interpret the trees biologically.
Results and Discussion
Overview of the Multi-Sample Cancer Phylogeny
Inference Method, LICHeE
LICHeE is a method designed to reconstruct cancer
cell lineages using SSNVs from multiple related nor-
mal and tumor samples of individual cancer patients,
allowing for heterogeneity within each sample. Given
a set of validated deeply sequenced SSNVs, LICHeE
uses the presence patterns of SSNVs across samples
and their VAFs as lineage markers by relying on the
perfect phylogeny model [32]. This model assumes that
mutations do not recur independently in different cells;
hence, cells sharing the same mutation must have in-
herited it from a common ancestral cell. This assump-
tion can be used to derive the following SSNV ordering
constraints. Firstly, (1) a mutation present in a given
set of samples cannot be a successor of a mutation
that is present in a smaller subset of these samples,
since it could not have arisen independently by chance
in the additional samples. Similarly, (2) a given muta-
tion cannot have a VAF higher than that of its prede-
cessor mutation (except due to CNVs), since all cells
containing this mutation will also contain the prede-
cessor. Finally, (3) the sum of the VAFs of mutations
disjointly present in distinct subclones cannot exceed
the VAF of a common predecessor mutation present
in these subclones, since the subclones with the de-
scendent mutations must contain the parent mutations
(this constraint is formally defined in the Methods sec-
tion). These constraints provide key information about
the topology of the true cell lineage tree and are lever-
aged by LICHeE to define the search space of the pos-
sible underlying lineage trees and evaluate the validity
of the resulting topologies. The final goal of LICHeE
is to find phylogenetic trees encoding an evolutionary
ordering of the input SSNVs that does not violate any
of these three constraints.
At a high level, the LICHeE algorithm can be broken
down into the following main steps (Figure 1). First,
LICHeE partitions SSNVs into groups based on their
occurrence in each sample, such that each group stores
all the mutations that were called in the same subset
of samples. To separate subclone lineages, the SSNV
members of each resulting group are then further clus-
tered based on their VAFs, such that SSNVs with sim-
ilar VAFs across samples are clustered together. The
final lineage tree needs to provide a valid ordering of
these resulting SSNV clusters (i.e. an ordering that
does not violate the three constrains defined above).
In order to find such a tree, we construct an evolution-
ary constraint network, which encodes whether a given
cluster of SSNVs could have preceded another, for each
pair of clusters. More specifically, this network is an
acyclic directed graph (DAG) that has SSNV clusters
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Figure 1 (a) Toy example of five samples (Lymph control and four tumor samples S1– S4) with one germline SNV and four SSNVs,
each associated with a binary sample profile. (b) SSNVs are partitioned into groups based on their binary profile (displayed groups
contain other SSNVs with varying VAFs). (c) Group SSNV are clustered based on their VAFs. (d) The clusters of each SSNV group
are incorporated into an evolutionary constraint network. An edge is placed between a parent and child node if, for each sample, the
VAF of the parent is greater than or equal that of the child node. For example, this constraint is violated for the green 01110 node
and node 00110. (e) The lineage tree is constructed from the constraint network. The leaves of the tree are the individual samples.
The horizontal line subdivisions in a sample indicate mixed lineages, separating the different subpopulations of cells in the sample.
The colors in each subdivision describe the mutation groups that the cells in this subpopulation have. Consider the orange node
01110, which denotes SSNVs of class 01110. Those SSNVs are found in samples 1, 2, and 3. After an ancestral cell division, the
daughter cells’ lineages accumulated SSNVs too (01110, green; 00110) that are now present in their descendant samples or
subclones. About 20% of sample 1 are cells that come from the orange and green lineage, and about 40% come from the blue
lineage. Samples 1, 2, and 3 grew from two or more subclones, whereas sample 4 only grew from one subclone.
as its nodes and whose edges encode possible prede-
cessor relationships among the nodes’ mutations (i.e.
an edge denotes that the mutations of a given pair of
clusters satisfy ordering constraints (1) and (2)). This
network greatly reduces the search space of possible
valid trees and allows us to formulate the task of in-
ferring such trees as a search for spanning trees of the
network that satisfy constraint (3) (within a given er-
ror margin), which ensures that the reconstructed trees
are composed of parent-daughter edges that exhibit
somatic VAF consistency with the cell lineage expan-
sion. If multiple valid lineage trees are found during
the search, the trees are ranked based on how well
they support the cluster VAF data, the top-ranking
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tree minimizing the use of the permitted error margin
(see Methods for details). Finally, as shown in Figure
1, the leaves of the resulting trees are the individual
samples (added post-search), whose composition can
be reconstructed by tracing back their respective sub-
clone cell lineages in the tree. We detail each of these
steps in Methods.
Since finding true SSNV groups is a crucial step of
the algorithm, it is important to minimize false pos-
itive and false negative SSNV calls across samples.
However, accurately detecting SSNVs in each sample
is a challenging task due to high levels of noise in
the data, which can come from various sources, such
as sequencing errors, systematic amplification bias,
mapping errors, and sample impurities. Multiple tech-
niques have been developed to address this problem
to date [33–37], many employing a Bayesian approach
to model the distributions of noise and true genotypes
in matched-normal samples. LICHeE can work with
variant calls produced for each sample by any special-
ized existing method. However, it does not require the
users to pre-process the data using these tools, provid-
ing its own heuristic mechanism to call SSNVs using
the multi-sample VAF data. At a high level, it first
finds SSNVs that can be called reliably in each sample
using two hard thresholds Tpresent and Tabsent, above
and below which, respectively, the SSNV are consid-
ered robustly present or absent. Then, assuming that
the presence patterns of such SSNVs capture most of
the topology of the true underlying evolutionary tree,
it uses this inferred tree to inform the group assign-
ment of the SSNVs whose VAF falls in between the
thresholds (the ’greyzone’).
Currently LICHeE does not automatically detect or
incorporate the CNVs explicitly into the model, al-
though the method can still find valid phylogenies even
in the presence of SSNVs within such regions (for ex-
ample, each patient in the ccRCC dataset had nu-
merous variants from CNV regions). In order to ad-
dress this limitation, LICHeE also accepts cell preva-
lence (CP) values instead of VAFs, which can be com-
puted by several recently-developed tools, such as Py-
Clone [12], ABSOLUTE [8], and ASCAT [38], and ac-
count for CNVs, LOH status, and sample purity. The
same algorithmic steps can then be directly applied to
CP values of each variant. It can be easily seen that
the three perfect phylogeny ordering constraints still
hold for CP values and can be used to search for the
underlying lineage tree. Furthermore, in order to sup-
port outputs of specialized clustering approaches (e.g.
PyClone [12]), LICHeE also accepts already computed
clusters of mutations (with given CP and VAF-based
centroid values) and uses these clusters as nodes of the
phylogenetic constraint network.
We evaluated LICHeE on three recently published
ultra-deep sequencing multi-sample datasets of clear
cell renal cell carcinoma (ccRCC) by Gerlinger et.
al [21], high-grade serous ovarian cancer (HGSC) by
Bashashati et. al [27], and breast cancer xenoengraft-
ment by Eirew et. al [30], as well as on simulated
trees of heterogeneous cancer cell lineage evolution. On
the ccRCC dataset, LICHeE constructs near-identical
trees to the trees published in the study. We show
that the interesting difference in the topology of one
tree arises due to potential heterogeneity of a sample
that cannot be discovered using the traditional maxi-
mum parsimony approach and analyze when this ap-
proach can fail to detect existing sample subclones. For
each patient LICHeE finds a unique valid tree. On the
HGSC datasets we show that the trees generated by
LICHeE are better supported by the data and demon-
strate why applying neighbor joining with Pearson cor-
relation distance metric, used by the study, might not
be suitable for cancer datasets. LICHeE finds a unique
valid tree for all patients except Case5. Finally, we
show that the trees inferred by LICHeE on the xeno-
engraftment dataset are consistent with the single-cell
analysis done by the study. On each patient dataset
LICHeE takes only a few seconds to run.
Lineage Tree Reconstruction on ccRCC Data
The ccRCC study by Gerlinger et. al [21] validated
602 nonsynonymous nucleotide substitutions and in-
dels from multiple samples of 8 individuals. It used
VAF-based clustering of each sample to detect sub-
clones prior to determining the variant presence pat-
terns used in tree reconstruction. The phylogenetic
trees were then reconstructed using maximum parsi-
mony, revealing a branched pattern of ccRCC evolu-
tion in all tumors. Figure 2 juxtaposes the trees pro-
duced by LICHeE with the trees presented by Ger-
linger et. al [21] (for details about the parameters
used by LICHeE and the ccRCC dataset see Appendix
B). The trees presented in the figure have been re-
drawn using AI. We can see that the trees generated
by LICHeE are topologically identical (consisting of
the same branches) to the published trees for patients
EV005, EV007, RMH002, RMH008, and RK26. Fur-
thermore, LICHeE identified subclones in all the sam-
ples reported to be heterogeneous by the study. In par-
ticular, it identified the following regions as a mixture
of two subclones: R6 in EV005 (with frequencies of
0.29 and 0.04), R3 and R9 in EV007 (with frequencies
of 0.15 and 0.03 and 0.21 and 0.03, respectively), R4
and R6 in RMH008 (with frequencies of 0.19 and 0.14
and 0.21 and 0.15, respectively), and R5 in RK26 (with
frequencies of 0.15 and 0.03). These subclones corre-
spond to the dominant (dom) and minor (min) shown
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Figure 2 Comparison of lineage trees for ccRCC patients 001-008. Phylogenetic trees obtained with LICHeE (on the left) are
contrasted with the trees published in [21] for each patient in the study.
in the published trees. Evidence supporting each sub-
clone can be analyzed using the presented trees.
The trees generated for patients EV003 and EV006
also highly match the published results. For EV006,
the LICHeE-generated tree does not contain the fol-
lowing two partially shared groups: (R2, LN1a, and
LN1b) and (R3, R1, R4, R7, R15). For the first group
we find no evidence in the data – no SSNVs are shared
in these three samples and absent from the others. We
do find one mutation that supports the second group.
Because, by default, LICHeE eliminates nodes that
have evidence from only one SSNV, this group is not
shown in our tree.
The RMH004 dataset contains three partially over-
lapping groups (R3, VT, R10, R4, R2), (R3, VT, R10,
R4, R8), and (R10, R4, R2, R8). These groups rep-
resent separate branches where their lowest common
ancestor is the group with mutations present across
all samples (R3, VT, R10, R4, R2, R8). However, the
VAF of this parent group in sample R10 is 0.34, while
the average VAF across each of the three groups is 0.32,
0.27, and 0.21, respectively. Therefore, no more than
one of these groups can be a descendant of the parent
group, without violating the VAF phylogenetic con-
straint. In order to generate a valid tree, the two least
populated conflicting branches among the three are
removed from the dataset. Similarly, these two groups
are ignored by the maximum parsimony algorithm and
are not present in the published tree. The difference be-
tween our tree and the published one comes from the
mixed lineage we observe in sample R4. Due to the
VAF of 0.17 of the group of R4 private mutations, the
private group is not a descendant of the group shared
by R4 and R2 since the average VAF of that node is
0.06, which is too small to be a parent to 0.17. There-
fore, our method suggests two different subclones in
R4. Since the group (R2, R4) is small (total of three
mutations) and has a low frequency in R4, the evi-
dence of the two subclones cannot be considered very
strong; however, it does constitute a signal in the data
for the R4 mixed lineage possibility.
While the ccRCC study does perform VAF cluster-
ing of each sample to find subclones at the onset, it
runs the phylogenetic reconstruction using the pres-
ence pattern profiles only. On the other hand, our
tree reconstruction with LICHeE applies the VAF con-
straint to the resulting tree topologies and clusters
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SSNVs in each group based on their VAFs across all
the samples. For patient RMH004, applying the VAF
constraint, reveals additional sample heterogeneity, for
which we produced a potentially improved tree com-
pared to the tree reported using maximum parsimony.
It can also be shown that clustering across all the sam-
ples rather than each sample individually, is a more ap-
propriate approach for revealing the heterogeneity in
the data. For example, if two subclones occur with high
and low VAFs in one sample but are uniform in an-
other sample, single sample clustering will detect them
only in the sample where they differ. For example, if
the two subclones in samples R3 and R9 of patient
EV007 (discussed above) had highly similar VAFs in
these samples, clustering would not be able to differen-
tiate the subclones. On the other hand, LICHeE would
still be able to detect the mixed lineages in the two
samples due to the presence of groups (R1, R2, R3,
R5, R6, R7, R9) and (R3, R4, R9) in the data, which
must form divergent branches in the lineage tree.
Lineage Tree Reconstruction on HGSC Data
We further evaluated LICHeE on the HGSC dataset
from the study by Bashashati et. al. [27]. This study
validated 340 somatic mutations from 19 tumor sam-
ples of six patients. It used neighbor joining with
Pearson correlation distances (computed on the bi-
nary sample presence patterns) to infer lineage trees.
The trees generated by LICHeE juxtaposed with those
presented in the paper are shown in Figure 3 (for de-
tails about the parameters used by LICHeE and the
HGSC dataset see Appendix B). In four out of six
cases (Case2, Case3, Case 4, and Case6) the possible
tree topologies are very simple and the trees produced
by the two methods are unsurprisingly highly similar.
Below we discuss the difference between the two re-
maining trees.
For Case1 the tree reported in the paper suggests
that sample d diverged first, followed by c. This sug-
gests that there should be a group of mutations shared
exclusively between samples a and b and another group
shared between samples a, b, and c. However, examin-
ing the dataset VAF values, as well as the results of the
binomial test determining SSNV presence in the sam-
ples used by this study, we found no evidence for these
two groups. On the other hand, the tree produced by
LICHeE suggests the presence of mutations shared by
samples a, b, and d only, which we found both in the
results of the study’s binomial test and by applying
the LICHeE hard threshold caller.
For Case5, the study reports an early divergence of
sample c. This suggests that there should be mutations
shared between all the samples except c. We have con-
firmed that no such mutational profile exists in the
data. On the other hand, the data shows the presence
of mutations that exist in samples a, b, c, e, and f but
not in d that cannot be supported by the reported tree.
The reason why the neighbor-joining algorithm of the
study chose sample c as the first diverging branch of
the tree must be because of the large presence of pri-
vate mutations in sample c, which led to a low Pear-
son correlation (and hence a greater distance) with
the profiles of other samples. This shows that using
the Pearson correlation metric is not suitable for this
data. Furthermore, directly applying traditional phy-
logeny reconstruction techniques (e.g. neighbor join-
ing) cannot reveal sample heterogeneity.
The tree produced by LICHeE for Case5, reveals
mixed lineages in samples b, e, and f. Interestingly,
LICHeE detects two clusters in group (a, b, c, e, f)
with mean VAFs of [0.29, 0.34 0.3, 0.19, 0.4] and
[0.17, 0.14, 0.13, 0.1, 0.13], respectively. The two sub-
clones in each sample are then produced by the di-
vergence of the higher VAF cluster into two branches:
one branch containing the lower VAF cluster and the
other branch containing the group of mutations (e, f,
b). While the presence of group (e, f, b) is weak (sup-
ported by three mutations only), the presence of group
(b, f) is substantial (supported by 14 mutations) and
provides strong evidence for the mixed lineage of b
and f. Furthermore, due to the presence of group (a,
b), the group (b, f) cannot be assigned as a child of
the low VAF cluster (a, b, c, e, f) without violating
the VAF phylogenetic constraint. However, since there
are only three mutations in group (a, b), eliminat-
ing this group may be a reasonable alternative recon-
struction. Therefore, multiple topologies are possible
in this scenario, each supported by varying degrees of
evidence. LICHeE presents the tree that best fits the
data given input parameters of expected noise level
and minimum mutational support needed for a node.
Using LICHeE with different parameters and interact-
ing with the trees can allow users to explore other ev-
idence existing in the data. It is important to point
out that, as opposed to the results of the neighbor-
joining algorithm that produces trees with lack of ev-
idential support in some branches, each branch in a
tree reported by LICHeE reflects the presence of the
corresponding SSNV groups in the data.
Lineage Tree Reconstruction on Xenoengraftment Data
The study by Eirew et. al. [30] used deep-genome and
single-cell sequencing to evaluate the clonal dynamics
of xenoengraftment of breast cancer tissue into immun-
odeficient mice. The study applied PyClone [12] to in-
fer mutational clusters representing clonal genotypes
and then validated these results using single-cell anal-
ysis of two cases, SA494 and SA501. The study used
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Figure 4 LICHeE reconstruction on breast cancer xenoengraftment data [30]. a, Lineage tree generated by LICHeE (on left) is
juxtaposed with the phylogeny derived from single-cell data in the study (on right) for SA501. b, Lineage tree generated by LICHeE
for SA494.
Bayesian phylogenetic inference to reconstruct the evo-
lutionary relationships between the single-cell nuclei.
We applied LICHeE to the deep-sequencing VAF data
of this study. We then compared the results of LICHeE
to the single-cell phylogenetic trees and clonal geno-
types for both SA494 and SA501.
Single-cell phylogenetic inference of SA501 passages
X1, X2, and X4 reveals an ancestral genotype that
branched into two sibling clades A and B. Sequen-
tial acquisition of additional mutations in clade B then
gave rise to genotypes C, D, and E. Samples X1 and X2
were found to be a mixture of clones with genotypes A,
B, C, and D; while, sample X4 was found to be domi-
nated by genotype E and did not contain clones with
genotype A (see Figure 2 in [30]). As can be seen in Fig-
ure 4a, the tree reconstructed by LICHeE mirrors the
phylogeny and sample compositions revealed by the
study. In particular, it presents the same two sibling
clades derived from the ancestral genotype. Samples
X1 and X2 both contain subclones with genotype A
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(with a higher percentage of this genotype in sample
X2, as confirmed by the single-cell analysis), while this
genotype is missing from sample X4. Similarly, geno-
type E is found to be private to and dominates sample
X4. The only difference in the LICHeE tree is the col-
lapse of genotypes B and C into one cluster; however,
examining the bulk CP values reported by the study,
we can see that the CP values of these genotypes are
highly similar in the three given samples (X1, X2, and
X4) and, as a result, cannot get subdivided into two
separate clusters during the clustering step (note: the
PyClone analysis of the study was simultaneously per-
formed on three additional samples T, X3, and X5,
which showed higher CP value differences).
The single-cell analysis of SA494 samples T and X4
reveals two clades, with mutually exclusive sets of mu-
tations, emerging from an ancestral clone present in
both samples (see Extended Data Figure 3 in [30]).
LICHeE reconstructs the exact same topology (Fig-
ure 4b), showing two groups of mutations private to T
and X4, respectively. In accordance with the results re-
ported by PyClone, LICHeE also finds two clusters of
mutations private to X4 (with the descendant cluster
present in about 20% of the sample).
Simulations
We developed a cancer cell lineage simulator to bet-
ter asses the performance of LICHeE. Our simulator
models cancer evolution from normal tissue producing
a branching hierarchy of monoclonal cell populations
in accordance with the branched-tree cancer evolution
model [26,39,40]. Starting with the normal cell popula-
tion, the simulator iteratively expands the cell lineage
tree by introducing (with some given probability) new
daughter cell populations corresponding to newly ac-
quired SSNV or CNV events. In particular, in every
iteration, each cell population present in the tree can
give rise to a new population of cells (with a given
randomly generated size) representing a new SSNV
with probability PSSNV or a CNV event with prob-
ability PCNV . Each cell population can also undergo
a cell death event with probability PDeath. Each simu-
lated SSNV is randomly associated with a genome lo-
cation (chromosome and position) and haplotype; the
CNVs are associated with a chromosome arm and hap-
lotype and correspond to a duplication of this chromo-
some arm. For the evaluation, we generated 100 lineage
trees, each expanded over 50 iterations, with the fol-
lowing parameters: PSSNV = 0.15; PCNV = 0, 0.1, and
0.18; and PDeath = 0.06. This process results in lineage
trees with an arbitrary number of branches and nodes
(several hundred to thousands of nodes on average).
Figure 5 illustrates one such lineage tree.
Multiple samples are then collected from each lin-
eage tree. Each sample consists of several cell popu-
lations (nodes) of the tree, where each such cell pop-
ulation represents a subclone in the sample. We im-
plemented two sampling schemes: randomized sam-
pling and localized sampling. The randomized sam-
pling process selects a random subset of nodes from
the tree for each sample; on the other hand, the local-
ized sampling process is meant to mimic biopsies from
spatially distinct sites and selects nodes such that sam-
ples mostly contain subclones from distinct branches
of the simulated tree. Localized sampling for n sam-
ples is achieved by selecting n disjoint subtrees in the
simulated tree using an approach based on breadth-
first search, which finds disjoint subtree roots as high
on the tree as possible (if n disjoint subtrees do not
exist in the tree, the maximum number of subtrees is
used and some samples are obtained from the same
subtree in a round-robin fashion). Figure 5 illustrates
the localized sampling procedure for 10 samples.
Given a selected subset of cell populations, the sam-
ple is then created by obtaining a fraction of the cells
from each population by sampling from a multino-
mial distribution with probabilities corresponding to
the cell population sizes. For randomized sampling,
we select up to 5 subclones for each sample. For lo-
calized sampling, there can be up to 5 subclones from
the same distinct subtree, exactly one subclone from
a neighboring subtree, and some fraction of normal
cells to represent normal contamination (the fraction
is randomly selected to be from 0 up to 20% of the
sample). In order to determine how the performance
of LICHeE degrades as the number of SSNVs located
in CNV regions grows, we ran several experiments with
increasing numbers of CNV events. In particular, we
set PCNV = [0, 0.1, 0.18], which resulted in a total of
0%, 65%, and 80% of SSNVs to be affected by CNVs
in the collected samples, respectively. Given the sam-
ple cell population counts, we can compute the VAF
of each SSNV in this sample. In the absence of CNVs,
the VAF of a given SSNV is simply the fraction of
the cells containing the SSNV out of all the cells in
the sample. When CNVs are present, we count the
number of haplotypes containing the SSNV and the
reference allele across all cells of the sample. Given an
SSNV, we consider the chain of mutations present in
each cell population affecting its genome position. Let
HvP be the number of haplotypes containing the SSNV
in population P and HrP be the number of haplotypes
containing the reference allele. The VAF of a given
SSNV M is then:
V AF (M) =
∑N
P=1 Pn·HvP∑N
P=1 Pn·(HvP+HrP )
,
where N is the total number of selected populations
and Pn is the number of cells selected from population
P .
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Figure 5 Example of a small simulated lineage tree (with SSNV and CNV events) with localized sampling (10 samples total
indicated by different colors). Each node represents a cell population that contains every mutation in its lineage. Gray indicates dead
cell populations.
Finally, given the true VAFs of each SSNV, we add
sampling and sequencing noise to each value. In par-
ticular, in order to simulate reads covering each SSNV
position, we sample the VAFs from the Binomial distri-
bution B(n, p), where p is the true VAF of each SSNV
and n is the total simulated read coverage (100X,
1,000X, and 10,000X); the generated frequencies have
a mean p and variance p(1−p)n . We simulate a Q30 (1
in 1000) base call sequencing accuracy.
Given the simulated VAFs, we first assessed the per-
formance of LICHeE in SSNV calling. Table 1 presents
LICHeE’s sensitivity in calling mutations across the
samples (i.e. the number of SSNVs with correctly iden-
tified sample presence patterns out of all the simulated
SSNVs) given true VAF values and for coverages of
100x, 1,000X, and 10,000X. As expected, higher cov-
erage results in higher sensitivity. The method achieves
94− 99% sensitivity across all the experiments.
Next we compared the topology of the reported
lineage trees and the simulated trees and measured
LICHeE’s accuracy in reconstructing the ancestor-
descendant and sibling relationships. For every pair
of mutations in the simulated tumor hierarchy, we
checked if LICHeE preserved the relationship between
them in the generated top tree. More specifically, we
checked for the following two types of violations: 1)
if an ancestor-descendant relationship was inverted or
became a sibling relationship, and 2) if a sibling rela-
tionship became an ancestor-descendant relationship.
Tables 2 and 3 summarize the accuracy of these met-
rics. Since LICHeE may remove nodes from the net-
work representing non-robust SSNV groups (as de-
scribed in Methods) if no valid trees are found during
the search, not all of the simulated mutations will be
present in the final tree. We report the percentage of
the SSNVs and of simulated ancestor-descendant (AD)
and sibling (Sib) mutation pairs that are present in the
tree. As expected, the number of mutations present in
the trees decreases with higher numbers of input sam-
ples, lower coverage, and the presence of CNVs (which
can significantly alter the VAF values, causing the vio-
lation of the VAF ordering constraints). In particular,
with a low coverage of 100X and 15 samples, only 81%
of SSNVs are preserved in the tree. Therefore, LICHeE
is best applied to data with higher coverage when the
number of input samples is high. For instance, with a
higher coverage of 1,000X, 91-94% of SSNVs and 83-
88% of mutation pairs are present in the trees with 15
samples (although this metric drops with the presence
of CNVs to 91-92% SSNVs and 66-70% SSNV pairs).
Since LICHeE groups mutations with the same pres-
ence patterns across samples and similar VAFs, only
the mutations occurring in a different set of samples
or with significantly different VAFs will be placed in
distinct nodes of the tree. We report the percentage of
such ancestor-descendant pairs (AD-Ord) in Tables 2
and 3. We then evaluate how many ordered mutations
preserved the correct ancestor-descendant relationship
(AD-Corr). Across all the experiments without CNVs,
we get 99-100% correctness (with less than 1% of pairs
being in reversed order). We see 92-96% correctness in
experiments with 80% of SSNVs located in CNV re-
gions and 1000X coverage. AD mutations that were not
ordered or grouped in the same node, will be siblings
in the reconstructed tree (AD →Sib). We find that
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the vast majority of such mutation pairs involve pri-
vate mutations, whose placement in the tree is usually
under-constrained (i.e. multiple tree nodes can serve
as ancestors to such mutation groups). Finally, we can
see that the reverse violation of sibling mutations be-
ing placed into ancestor-descendant nodes (Sib→AD)
is also very rare (up to 7% across all the experiments).
Therefore, we conclude that the trees reconstructed by
LICHeE provide highly accurate ordering of the mu-
tations in its nodes.
Conclusion
LICHeE has been designed to automatically infer cell
lineages of multiple tumor samples and the sample sub-
clone decomposition. Our analysis shows that LICHeE
is highly effective in reconstructing the phylogenies
and uncovering the heterogeneity of previously pub-
lished datasets and in simulations, improving not only
upon traditional tree-building methods, but also on
recent developments specialized for cancer data. Cur-
rently LICHeE works with deep sequencing data that
provides VAF estimates with low variance (as well as
on CP values that can be obtained from existing tools
and can correct for SCNAs, LOH, and sample pu-
rity). SSNV data obtained from deep whole-genome
sequencing, targeted resequencing of informative SS-
NVs, or exome sequencing in tumors with a high de-
gree of somatic SSNVs present in exomes, should be
appropriate inputs to LICHeE. Several directions for
future work are open: extension of this method to lower
coverage whole-genome sequencing data and incorpo-
ration of aneuploidies and large CNVs directly into the
model.
Methods
Grouping and Clustering SSNVs
When partitioning SSNVs into groups based on sam-
ple occurrence, each SSNV is first associated with a
binary sample profile denoting its presence or absence
in each sample. Given S samples from an individual,
the binary profile is defined as a binary sequence of
length S where the ith bit is set to 1 if this SSNV is
called in the ith sample, and is 0 otherwise (e.g. given
5 samples, an SSNV with the profile 01011 is called in
samples 2, 4, and 5). SSNVs with the same profile are
assigned to the same SSNV group (e.g. a group with
the profile 01101 will contain all the SSNVs occurring
in samples 2, 3, and 5). The group with the profile
consisting entirely of 1s will contain SSNVs that occur
in all the samples and are, therefore, germline vari-
ants (assuming that the sample set includes a normal
control sample).
The SSNV binary profiles can be passed as input or
computed from SSNV VAFs as follows. First two hard
VAF thresholds, Tpresent and Tabsent are used to de-
termine if an SSNV is robustly present or absent from
a sample. An SSNV profile is classified as robust if its
VAF is above or below the two thresholds, respectively,
and if at least a minimum number of other robust SS-
NVs (default set to one) have the same binary pro-
file. All other SSNVs are considered non-robust and
are assigned to a group as follows. Given a non-robust
SSNV m, its VAF across samples can either fall below
(marked 0), above (marked 1), or in between (marked
*) the thresholds Tpresent and Tabsent, resulting in a
profile such as 01*11. The candidate groups, to which
m can be assigned, must have an identical profile in
all the samples that are marked 0 or 1 (e.g. for pro-
file 01*11 two valid candidate groups are 01111 and
01011). Since m can be assigned to more than one
target group, we consider that the group containing a
robust SSNV that is most similar in VAF to m is the
best candidate. The following metric is used to com-
pute the similarity between two SSNVs m and n:
simmn =
∑
i∈samples
min(m.VAFi, n.VAFi)
max(m.VAFi, n.VAFi)
, (1)
where m.VAFi is the VAF of m in sample i. If the max-
imum similarity is higher than a given threshold, m
is assigned to the group of argmaxn∈Candidatessimmn.
Unassigned non-robust SSNVs will form new profile
groups. We minimize the number of such new groups
by formulating this task as a set cover problem. In par-
ticular, let X be the set of all unassigned SNVs. De-
note Y as the set of subsets of X, where each subset
represents mutations that can be assigned to the same
potential target group. The target groups are a list
of all possible binary profiles that the SSNVs can be
assigned to, obtained by substituting all *s by 0 or 1.
We want to find the minimum number of target groups
(i.e., smallest subset of Y ), which cover all mutations
in X. This problem is known to be NP-complete and
searching for the exact solution is not feasible. Instead
we apply the standard greedy algorithm by choosing
(at each stage) the target group that covers the largest
number of non-robust SSNVs. For SSNVs whose tar-
gets are not supported by any other mutations, we
convert each * to 1 or 0 depending on whether the
VAF is closest to Tpresent or Tabsent, respectively.
Once the SSNVs are partitioned into groups, the SS-
NVs of each group are further clustered based on their
sample VAFs. Each SSNV group is associated with a
matrix M of VAFs of size n×s, where n is the number
of SSNVs in this group and s is the number of repre-
sented samples (e.g. s = 3 for a group with the profile
0110001). The EM clustering algorithm for GMMs is
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Figure 6 Evolutionary constraint network for patient EV007 with 8 tumor samples and 55 SSNVs. Each node is associated with the
binary profile of its corresponding SSNV group, the VAF centroid, and the number of SSNVs assigned to it. The edges represent the
potential precedence relationships between the node SSNVs. The spanning tree reported for patient EV007 is highlighted (see
Results).
run on the resulting VAF matrix M using [41]. The re-
sult is a set of SSNV clusters with an associated VAF
centroid vector, ~V AF . To handle the high variance in
the VAF data due to noise, some of the resulting clus-
ters are eliminated (based on size) or collapsed with
neighboring clusters, based on the distance between
their centroid vectors.
Evolutionary Constraint Network Construction
Given the clusters of each SSNV group, we construct
an evolutionary constraint network to capture valid
evolutionary timing relationships between the muta-
tions of each cluster pair. The network is a DAG, where
each node corresponds to an SSNV cluster (except the
root, which represents the germline) and each edge be-
tween two nodes, (u→ v) denotes that parent node u
could be an evolutionary predecessor of child node v
(i.e. that SSNVs in cluster u could have ”happened
before” SSNVs in cluster v). In particular, an edge
(u → v) is added only if the nodes satisfy the fol-
lowing two constraints ∀i ∈ samples (which guarantee
that the network will be acyclic):
(1) u.VAFi ≥ v.VAFi − uv and
(2) if u.VAFi = 0, v.VAFi = 0 ,
(2)
where uv is the VAF noise error margin (note: the
error margin is the maximum of the sum of the stan-
dard errors for sample i of the two clusters and a con-
figurable parameter). In the resulting network, each
node will have at least one parent (since all nodes can
be connected to the root). We avoid checking all node
pairs, by organizing the nodes into levels according to
the Hamming weight (i.e. number of 1s) of the binary
group profile to which they belong. Nodes that are in
the same level and have conflicting binary profiles can-
not satisfy the above constraints. Nodes from different
levels can only be connected such that the node in
the higher level is the parent of the node in the lower
level. Finally, for nodes that are in the same level and
have the same binary profile, the edge is added in the
direction that minimizes VAFERR, where:
VAFERRu→v =
∑
i∈samples
~1ERR · (v.VAFi − u.VAFi)2
(3)
with the indicator function:
~1ERR =
{
1, v.VAFi > u.VAFi
0, otherwise
. (4)
Figure 6 illustrates the constraint network produced
for the dataset of ccRCC Patient EV007 (described in
the Results section).
Phylogenetic Tree Search
By the constraint network construction, a valid lineage
tree T of the SSNV clusters (i.e. a tree that does not
violate the three constraints of the perfect phylogeny
model) must be a spanning tree of the network that
satisfies the following requirement ∀ nodes u ∈ T :
∀i ∈ samples :
∑
v s.t. (u→v)∈T
v.VAFi ≤ u.VAFi+ .
(5)
That is, the sum of the VAF centroids of all the chil-
dren must not exceed the centroid of the parent. We
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use inequality here since our method does not require
all the true lineage branches to have been observed.
To tolerate noise in the VAF data, we relax the con-
straint by allowing the sum of children VAFs to exceed
the parent by an error margin . Given such a valid lin-
eage tree, each sample can then be decomposed into
subpopulations by enumerating all the paths in the
tree starting with the germline root and ending in the
last node containing mutations in that sample.
The problem of finding all such trees is equivalent to
the problem of finding all spanning trees of the con-
straint network DAG for which Eqn. (5) holds. We
have extended the Gabow and Myers spanning tree
search algorithm [42] to generate all such spanning
trees. The original algorithm generates all spanning
trees of a directed graph using backtracking and an
efficient bridge edge detection method based on DFS.
Our extension consists of enforcing Eqn. (5) during the
tree search by terminating the expansion of a given tree
and backtracking as soon as an edge violating Eqn. (5)
is added (see Algorithm 1). Same as the original algo-
rithm, this search runs in O(|V | + |E| + |E|N) time,
where |V | is the number of nodes, |E| is the number
of edges, and N is the number of spanning trees in the
network. While the runtime of the program depends
on the number of spanning trees in the constraint net-
work, in practice the search is very fast (taking on the
order of a few seconds). However, since, in theory, it is
possible for the algorithm to take longer on datasets
that result in constraint networks with many spanning
trees, we provide a bound on the maximum number of
lineage trees to generate in order to avoid searches that
are too long. Similarly, we also have a high bound on
the number of calls to the GROW procedure in Algo-
rithm 1. We expect this scenarios to be very rare in
typical validation datasets. To reduce search space we
also optionally constrain the placement of private mu-
tation nodes in the constraint network to their closest
valid predecessors.
The above search algorithm will find all spanning
trees for which Eqn. (5) holds locally at each individ-
ual node; however, it is possible that in order to sat-
isfy this constraint, the centroid values are deviated
(within ) in a globally inconsistent way. Therefore, in
order to enforce consistency, we apply one additional
requirement to the trees returned by the search. In
particular, we formulate the following quadratic pro-
gramming (QP) problem to find a set of ev,i such that
for every sample i and node v:
minimize
∑
v
∑
i e
2
v,i
subject to∑
v s.t. (u→v)∈T
(
v.VAFi + ev,i
) ≤ u.VAFi + eu,i and
|ev,i| ≤ , ev,i ≤ v.VAFi
Algorithm 1 Finding All Lineage Trees
1: Initialization: f ← emtpy list, L← null // stores the last tree
output
2: procedure Lineage Tree Search(N) // N is a constraint
network rooted at r
3: Tree t← new empty Tree
4: t.addNode(r)
5: add all edges (r → v) ∈ N to f
6: grow(t)
7: procedure grow(t, N)
8: if t contains all the nodes in N then
9: L← t
10: output L
11: else
12: s← emtpy list
13: b← false
14: while (not b and f not empty) do
15: // e defined as (e.From → e.To)
16: Edge e← f.removeLast()
17: Node v ← e.To
18: t.addNode(v)
19: t.addEdge(e.From → v)
20: // ret. true if Eqn. (5) is satisfied for node e.From
21: if t.checkConstraint(e.From) then
22: add all edges (v → w), w 6∈ t to f
23: remove all edges (w → v), w ∈ t from f
24: grow(t)
25: if number of returned trees > max trees return
26: remove all edges (v → w), w 6∈ t from f
27: add all edges (w → v), w ∈ t to f
28: t.removeEdge(e.From → e.To)
29: N.removeEdge(e.From → e.To)
30: s.add(e)
31: if ∃ an edge (w → v) s.t. w not a descendent of v
in L then
32: b← false
33: else b← true
34: for all edges e starting from the end of s do
35: remove e from s, add e to f , add e to N
(6)
If no solution exists, the tree is considered invalid.
Since multiple valid lineage trees can be generated, we
rank them using the resulting ev,i solution, which cor-
responds to how well each tree fits the VAF data. The
top-ranking tree will be the tree with the minimum
sum of squared deviations:
∑
v
∑
i e
2
v,i. Since for cer-
tain networks the total number of valid lineage trees
can be large, it is impractical to run a QP program
on each tree. Therefore, we first rank the trees based
on the sum of squared deviations computed locally at
each node, and then run QP on the resulting top k
trees (k is 5 by default).
Multiple lineage trees can support a dataset equally
well since the placement of certain nodes in the tree
may be ambiguous using perfect phylogeny SSNV or-
dering constraints only (especially when not all lineage
branches have been observed). In these cases, more
sophisticated custom evaluation criteria would be re-
quired to rank the trees. We do not address defining
such criteria in this work. Instead we report all the
Page 13 of 18
 ID: Binary Prole (Size)
SSNV node selected
(a) SSNV group selected
Selected Sample
Subclone B
Subclone A
Selected Decomposition
(b) Sample selected
Figure 7 LICHeE graphical user interface output for top lineage tree of ccRCC patient RK26. (a) Information is displayed about the
SSNV members of the selected node. (b) Information is displayed about the sample composition.
produced trees to the user ranked by their associated
score (the number of trees reported is configurable)
and provide a GUI to allow the user to easily explore
the differences in the topologies (see the Visualization
for details). We expect that under any optimality cri-
teria, the sub-optimal trees can also represent signals
in the data of potential biological significance.
It is also possible that no valid lineage trees are found
during the search. This can happen if the noise error
margin is too narrow or the network contains nodes
corresponding to SSNV groups with a misclassified bi-
nary profile. In this case the network is adjusted and
searched again. Currently the network adjustment pro-
cedure will remove one-by-one all the nodes that be-
long to non-robust SSNV groups (smallest nodes first).
Other adjustments, such as increasing the noise er-
ror margin, are also possible but not currently imple-
mented.
Visualization
The constraint network and the phylogenetic trees can
be visualized and interacted with in GUI form. The
JUNG graph library [43] is used to generate the result-
ing graphs. When visualizing lineage trees, each input
sample appears as a leaf in the tree and is connected
to the nodes that contain SSNVs present in the sam-
ple. By clicking on the nodes of a tree, it is possible
to obtain additional information about each node. The
information displayed about an internal (non-sample)
tree node consists of its binary group profile, its cluster
centroid and standard deviation vectors, and the list
of the SSNVs in its cluster (these SSNVs can be anno-
tated with information from public databases such as
COSMIC, TCGA, etc). If a sample leaf node is clicked,
the information displayed consists of the lineage of this
specific sample obtained by doing a DFS traversal of
the tree starting with the germline root. Finally, the
user can rearrange the nodes in the tree, as well as
remove nodes and collapse nodes (provided they are
clusters of the same group). See Figure 7 for several
examples. In addition to the GUI, the program reports
the number of trees found and the score of the highest-
ranking tree. The user can control how many trees to
display.
Implementation
The LICHeE algorithm was implemented in Java. It is
open-sourced and freely available online at [31].
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Appendix A — Evaluation of Phylosub
We ran PhyloSub [29] on the Gerlinger et al dataset
[21] using default parameters. For each patient in the
dataset we compared the top tree structures (by de-
fault, three) with the published tree. It is hard to
find similarities between the topology of reported trees
and the published trees. Therefore, we analyzed the
performance of PhyloSub in finding the correct clus-
ters of mutations, which is a preliminary requirement
for building the cancer progression pathway. Gerlinger
et. al have categorized mutation groups as shared,
heterogeneous (partially shared), and private. Gen-
erally speaking, we observed that shared mutations
were clustered correctly but partially shared muta-
tions were often clustered all together as one group,
which violates their presence pattern. As an exam-
ple, PhyloSub reported a tree for patient EV003 with
three mutation groups (see Figure 8 below). The trunk
branch (colored blue) includes all shared mutations
as well as one private and two partially shared mu-
tations. Second branch (colored green) contains sev-
eral partially shared mutations and the rest of pri-
vate mutations with very different presence patterns,
and the third branch (colored red) contains three
partially shared mutations. Case EV003 has a het-
erogenous group with 8 mutations shared by R9 and
R6 (LONRF2, RHOB, BHLHE40, CMYA5, NOD1,
GCC1, SLC5A12, YLPM1), whereas PhyloSub puts
two of them in the trunk branch, four in the second,
and two in the third brach. Note that, as discussed in
the Results section, for EV003 LICHeE was able to
find all mutation groups and build the lineage match-
ing the reported tree in Gerlinger et. al dataset. For
other cases PhyloSub showed similar performance. We
also observed that PhyloSub does not deal with private
mutations properly. Often private mutations are either
clustered into singleton groups or are distributed into
shared or partially shared groups. For example, for six
out of eight patients in at least one of the top-trees
there are private mutations clustered with shared mu-
tations and located in the trunk branch of the corre-
sponding tree. Note that PhyloSub shows acceptable
performance in analyzing samples with very few mu-
tations and simple (chain) topology. However, when
tested on more complex multi-sample cancer datasets,
the performance of LICHeE is far more superior.
Figure 8 PhyloSub results for patient EV003.
Appendix B — Experimental Details of
the ccRCC, HGSC, and Xenoengraftment
Comparison
ccRCC. The clear cell renal cell carcinoma (ccRCC)
study by Gerlinger et. al [21] validated 602 nonsynony-
mous nucleotide substitutions and indels from multiple
samples of 8 individuals using ultra-deep amplicon se-
quencing with an average depth of>400x. The analysis
was performed on 587 out of these mutations guaran-
teeing a minimum coverage higher than 100x. Based
on the expected sequencing platform error rate, muta-
tions were called in a sample if their VAF was ≥ 0.5%
for substitutions and 1% for indels. In accordance with
the study, we set the cutoffs to Tpresent = Tabsent =
0.005 for calling SSNVs across samples for all patients
except RMH004 and required at least two mutations
as evidence of a node in the tree. For RMH004 we
set Tpresent = Tabsent = 0.01 to allow editing, observ-
ing that some mutations with the frequencies slightly
higher that 0.5% were considered absent in some sam-
ples of the study.
HGSC. In the high-grade ovarian cancer (HGSC)
dataset from the study by Bashashati et. al. [27], 19
tumor samples from six patients were used to validate
340 somatic mutations using deep amplicon sequenc-
ing (with a median coverage of > 5000x). When run-
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ning LICHeE, we used the hard thresholds of Tabsent
= 0.005 and Tpresent = 0.01 for all the patients except
Case5, where we used Tabsent = 0.01 and Tpresent =
0.04 due to a higher level of noise in the data, and re-
quired at least three mutations as evidence of a node in
the tree. For Case5 we also removed the samples g and
h from consideration since they had multiple inconclu-
sive validation results as stated in the manuscript [27].
Xenoengraftment. The study by Eirew et. al. [30]
used deep-genome and single-cell sequencing to evalu-
ate the clonal dynamics of xenoengraftment of breast
cancer tissue into immunodeficient mice. Single-cell
analysis was done on passages SA501 (samples X1,
X2, and X4) and SA494 (samples T and X4). When
running LICHeE on both passages, we used the hard
thresholds of Tabsent = 0.03 and Tpresent = 0.05 (the
value 0.05 was indicated in the study’s supplementary
materials); a minimum cluster size of 6 for non-private
mutations and 5 for private mutations; and a maxi-
mum cluster collapse distance of 0.085.
